# OnCo record urogen-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/urogen-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "urogen-pharma" ;
  schema:name "UroGen Pharma"@en ;
  schema:alternateName "UroGen Pharma Ltd."@en ;
  schema:description "UroGen Pharma is a United States-based pharmaceutical company running 3 late-stage cancer trials of UGN-103, UGN-102 and UGN-104 in bladder & urothelial cancer."@en ;
  schema:url <https://onco.cc/companies/urogen-pharma/>, <https://www.urogen.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.urogen.com>, <https://clinicaltrials.gov/search?lead=UroGen%20Pharma%20Ltd.>, <https://www.urogen.com/pipeline> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:drugs <https://onco.cc/drugs/ugn-103/>, <https://onco.cc/drugs/ugn-104/> ;
  onco:trials <https://onco.cc/trials/nct05243550/> .